Statement Of Cash Flows [Abstract]

LNA Santé - Filing #5981498

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for dividend income
203,000 EUR
20,000 EUR
Cash flows from (used in) operations before changes in working capital
147 987 EUR
4 324 EUR
143 663 EUR
146 626 EUR
142 742 EUR
3 884 EUR
Increase (decrease) in working capital
23 761 EUR
22 495 EUR
1 266 EUR
38 853 EUR
4 606 EUR
43 458 EUR
Adjustments for decrease (increase) in trade and other receivables
14 396 EUR
6 554 EUR
20 951 EUR
12 142 EUR
1 156 EUR
13 299 EUR
Adjustments for increase (decrease) in trade and other payables
24 625 EUR
2 874 EUR
21 751 EUR
1 058 EUR
6 979 EUR
5 921 EUR
Cash flows from (used in) investing activities [abstract]
Purchase of financial instruments, classified as investing activities
512,000 EUR
287,000 EUR
Proceeds from sales or maturity of financial instruments, classified as investing activities
405,000 EUR
415,000 EUR
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
6 136 EUR
5 113 EUR
Dividends paid to non-controlling interests, classified as financing activities
851,000 EUR
885,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.